FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and medicine and deals with composition for treatment of different forms and locations of tuberculosis. Claimed composition consists of sodium aminosalicylate and polyvinylpyrrolidone with molecular weight 8000-60000.
EFFECT: composition possesses high bioavailability and reduced local-irritate action of sodium aminosalicylate.
3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICINE FOR TREATING TUBERCULOSIS | 2009 |
|
RU2487702C2 |
ANTITUBERCULOUS DRUG | 2009 |
|
RU2466722C2 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 |
|
RU2424808C2 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION FOR PARENTERAL USE IN SMALL DOSAGES VOLUME | 2014 |
|
RU2578433C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
ANTITUBERCULOUS DRUG AND METHOD OF TREATING | 2010 |
|
RU2449797C1 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2417087C2 |
ANTITUBERCULAR PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2248797C1 |
Authors
Dates
2010-12-10—Published
2009-05-18—Filed